Talphera (TLPH) EPS (Weighted Average and Diluted) (2013 - 2025)
Talphera (TLPH) recorded quarterly EPS (Weighted Average and Diluted) of -$0.1 in Q1 2025, up 37.5% quarter-over-quarter from -$0.16 in Q1 2024, and up 37.5% on a YoY basis from -$0.07 in Q1 2024.
Talphera (TLPH) EPS (Weighted Average and Diluted) (2013 - 2025) Analysis & Trends
Talphera's EPS (Weighted Average and Diluted) history runs 10 years deep, the most recent figure standing at -$0.1 for Q1 2025.
- In Q1 2025, EPS (Weighted Average and Diluted) rose 37.5% year-over-year to -$0.1; the TTM figure through Mar 2025 stood at -$0.61 (up 32.97% YoY), while the FY2023 annual figure was -$0.72, down 109.93% from the prior year.
- EPS (Weighted Average and Diluted) was -$0.1 for Q1 2025 at Talphera, up from -$0.16 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $8.58 in Q2 2022 to a low of -$1.4 in Q3 2021.
- Historically, EPS (Weighted Average and Diluted) has averaged $0.27 across 5 years, with a median of -$0.27 in 2023.
- The sharpest annual moves came in 2022 and 2023: EPS (Weighted Average and Diluted) surged 10825.0% in 2022, then plunged 147.37% in 2023.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$1.22 in 2021, then soared by 146.72% to $0.57 in 2022, then slumped by 147.37% to -$0.27 in 2023, then surged by 40.74% to -$0.16 in 2024, then surged by 37.5% to -$0.1 in 2025.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.1 (Q1 2025), -$0.16 (Q1 2024), and -$0.27 (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 0.31 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 5.82 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.91 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -0.40 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -0.40 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.80 |
| 10 | Talphera | 56.42 Mn | 56.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -0.10 |
| Mar 31, 2024 | -0.16 |
| Dec 31, 2023 | -0.27 |
| Sep 30, 2023 | -0.08 |
| Jun 30, 2023 | -0.40 |
| Mar 31, 2023 | -0.75 |
| Dec 31, 2022 | 0.57 |
| Sep 30, 2022 | -0.65 |
| Jun 30, 2022 | 8.58 |
| Mar 31, 2022 | -0.56 |
| Dec 31, 2021 | -1.22 |
| Sep 30, 2021 | -1.40 |
| Jun 30, 2021 | -0.08 |
| Dec 31, 2017 | -0.20 |
| Sep 30, 2017 | -0.28 |
| Jun 30, 2017 | -0.29 |
| Mar 31, 2017 | -0.34 |
| Dec 31, 2016 | -0.21 |
| Sep 30, 2016 | -0.25 |
| Jun 30, 2016 | -0.24 |